Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-03

Clinical Trial Update: Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial update indicating plans to add a biotherapy or placebo to standard treatment for advanced or metastatic renal cell carcinoma; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma | Phase 3 | Status: NOT_YET_RECRUITING